Effect of Combination Treatment with GLP-1 Receptor Agonist and SGLT-2 Inhibitors on Incidence of Cardiovascular and Serious Renal Events . mfm [Internet]. 2024 Jun. 30 [cited 2025 Nov. 17];35(6). Available from: https://medicalforummonthly.com/index.php/mfm/article/view/4697